Alonso, J. C. http://orcid.org/0000-0002-1615-9724
Casans, I. http://orcid.org/0000-0002-3249-9446
González, F. M.
Fuster, D. http://orcid.org/0000-0003-0906-0627
Rodríguez, A. http://orcid.org/0000-0002-6068-3160
Sánchez, N. http://orcid.org/0000-0002-8565-1552
Oyagüez, I. http://orcid.org/0000-0002-3047-6152
Burgos, R. http://orcid.org/0000-0003-4295-8033
Williams, A. O. http://orcid.org/0000-0003-1982-8417
Espinoza, N. http://orcid.org/0000-0002-8116-6963
Article History
Received: 29 March 2022
Accepted: 20 June 2022
First Online: 2 July 2022
Declarations
:
: Not applicable.
: Not applicable.
: NEC and IO, are employees of Pharmacoeconomics & Outcomes Research Iberia (PORIB), a consultancy specialising in economic evaluation of health interventions, which has received private financial support from Boston Scientific in relation to the development of this work, including research, interpretation and writing of the manuscript. ARF has received consultancy and proctor fees from Boston Scientific. ICT has received lecture fee from Sirtex Medical. FMG, DF, JCA, NS, have no relevant financial or non-financial interests to disclose. AW, RB are employees at Boston Scientific Corp. NE, IO has received research support from Boston Scientific.